{"name": "Avaxia Biologics",
 "permalink": "avaxia-biologics",
 "crunchbase_url": "http://www.crunchbase.com/company/avaxia-biologics",
 "homepage_url": "http://www.avaxiabiologics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@avaxiabiologics.com",
 "phone_number": "781-861-0062",
 "description": "",
 "created_at": "Fri Nov 11 04:11:05 UTC 2011",
 "updated_at": "Sat Jun 08 03:13:48 UTC 2013",
 "overview": "\u003Cp\u003EAvaxia Biologics (www.avaxiabiologics.com) is a private, early stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes and obesity.\u003C/p\u003E\n\n\u003Cp\u003EAvaxia\u0026#8217;s lead product is a proprietary anti-TNF antibody to be administered to the oral cavity of patients suffering from mucositis. The antibody is designed to reduce the pain and ulceration associated with this serious side effect of cancer treatment. Avaxia is also developing a proprietary anti-TNF antibody to be administered orally to patients suffering from inflammatory bowel disease. Avaxia is also conducting discovery programs in the field of diabetes and obesity, targeting critical intestinal receptors associated with glucose metabolism.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       73],
      "assets/images/resized/0016/1874/161874v1-max-150x150.png"],
     [[199,
       98],
      "assets/images/resized/0016/1874/161874v1-max-250x250.png"],
     [[199,
       98],
      "assets/images/resized/0016/1874/161874v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Barbara",
      "last_name": "S. Fox",
      "permalink": "barbara-s-fox",
      "image": null}},
   {"is_past": false,
    "title": "COO",
    "person":
     {"first_name": "David",
      "last_name": "C. Dlesk",
      "permalink": "david-c-dlesk",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$17.1M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.finsmes.com/2012/02/avaxia-biologics-completes-4-1m-series-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Avaxia Biologics Completes $4.1M Series A Financing",
    "raised_amount": 4100000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 2,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Cherrystone",
         "permalink": "cherrystone",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Boston Harbor Angels",
         "permalink": "boston-harbor-angels",
         "image":
          {"available_sizes":
            [[[150,
               23],
              "assets/images/resized/0002/8947/28947v2-max-150x150.png"],
             [[250,
               38],
              "assets/images/resized/0002/8947/28947v2-max-250x250.png"],
             [[342,
               53],
              "assets/images/resized/0002/8947/28947v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Beacon Angels",
         "permalink": "beacon-angels",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0007/1418/71418v1-max-150x150.jpg"],
             [[250,
               43],
              "assets/images/resized/0007/1418/71418v1-max-250x250.jpg"],
             [[427,
               74],
              "assets/images/resized/0007/1418/71418v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "LaunchPad Venture Group",
         "permalink": "launchpad-venture-group",
         "image":
          {"available_sizes":
            [[[150,
               80],
              "assets/images/resized/0025/2026/252026v1-max-150x150.png"],
             [[180,
               96],
              "assets/images/resized/0025/2026/252026v1-max-250x250.png"],
             [[180,
               96],
              "assets/images/resized/0025/2026/252026v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Mass Medical Angels",
         "permalink": "mass-medical-angels",
         "image":
          {"available_sizes":
            [[[150,
               29],
              "assets/images/resized/0006/3979/63979v3-max-150x150.png"],
             [[250,
               48],
              "assets/images/resized/0006/3979/63979v3-max-250x250.png"],
             [[450,
               87],
              "assets/images/resized/0006/3979/63979v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "North Country Angels",
         "permalink": "north-country-angels",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0007/1530/71530v1-max-150x150.jpg"],
             [[250,
               52],
              "assets/images/resized/0007/1530/71530v1-max-250x250.jpg"],
             [[397,
               83],
              "assets/images/resized/0007/1530/71530v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "grant",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020120319e83jm7c8h\u0026r=Rss\u0026s=DJFVW",
    "source_description": "Avaxia Biologics Adds $1.5M From Phase II NIH Grant ",
    "raised_amount": 1500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 3,
    "funded_day": 19,
    "investments":
     []},
   {"round_code": "b",
    "source_url": "http://www.finsmes.com/2013/06/avaxia-biologics-completes-11-4m-series-financing.html",
    "source_description": "Avaxia Biologics Completes $11.4M Series B Financing",
    "raised_amount": 11500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 6,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Cherrystone Angel Group",
         "permalink": "cherrystone-angel-group",
         "image":
          {"available_sizes":
            [[[150,
               47],
              "assets/images/resized/0020/7367/207367v1-max-150x150.jpg"],
             [[250,
               78],
              "assets/images/resized/0020/7367/207367v1-max-250x250.jpg"],
             [[335,
               105],
              "assets/images/resized/0020/7367/207367v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Golden Seeds",
         "permalink": "golden-seeds",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0010/2188/102188v1-max-150x150.jpg"],
             [[215,
               63],
              "assets/images/resized/0010/2188/102188v1-max-250x250.jpg"],
             [[215,
               63],
              "assets/images/resized/0010/2188/102188v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "AbbVie",
         "permalink": "abbvie",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0026/2896/262896v1-max-150x150.jpg"],
             [[179,
               55],
              "assets/images/resized/0026/2896/262896v1-max-250x250.jpg"],
             [[179,
               55],
              "assets/images/resized/0026/2896/262896v1-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Tech Coast Angels",
         "permalink": "tech-coast-angels",
         "image":
          {"available_sizes":
            [[[130,
               58],
              "assets/images/resized/0003/0286/30286v1-max-150x150.png"],
             [[130,
               58],
              "assets/images/resized/0003/0286/30286v1-max-250x250.png"],
             [[130,
               58],
              "assets/images/resized/0003/0286/30286v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Beacon Angels",
         "permalink": "beacon-angels",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0007/1418/71418v1-max-150x150.jpg"],
             [[250,
               43],
              "assets/images/resized/0007/1418/71418v1-max-250x250.jpg"],
             [[427,
               74],
              "assets/images/resized/0007/1418/71418v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Boston Harbor Angels",
         "permalink": "boston-harbor-angels",
         "image":
          {"available_sizes":
            [[[150,
               23],
              "assets/images/resized/0002/8947/28947v2-max-150x150.png"],
             [[250,
               38],
              "assets/images/resized/0002/8947/28947v2-max-250x250.png"],
             [[342,
               53],
              "assets/images/resized/0002/8947/28947v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "LaunchPad Venture Group",
         "permalink": "launchpad-venture-group",
         "image":
          {"available_sizes":
            [[[150,
               80],
              "assets/images/resized/0025/2026/252026v1-max-150x150.png"],
             [[180,
               96],
              "assets/images/resized/0025/2026/252026v1-max-250x250.png"],
             [[180,
               96],
              "assets/images/resized/0025/2026/252026v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Mass Medical Angels",
         "permalink": "mass-medical-angels",
         "image":
          {"available_sizes":
            [[[150,
               29],
              "assets/images/resized/0006/3979/63979v3-max-150x150.png"],
             [[250,
               48],
              "assets/images/resized/0006/3979/63979v3-max-250x250.png"],
             [[450,
               87],
              "assets/images/resized/0006/3979/63979v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "North Country Angels",
         "permalink": "north-country-angels",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0007/1530/71530v1-max-150x150.jpg"],
             [[250,
               52],
              "assets/images/resized/0007/1530/71530v1-max-250x250.jpg"],
             [[397,
               83],
              "assets/images/resized/0007/1530/71530v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Granite State Angels",
         "permalink": "granite-state-angels",
         "image":
          {"available_sizes":
            [[[150,
               37],
              "assets/images/resized/0007/1438/71438v1-max-150x150.png"],
             [[250,
               62],
              "assets/images/resized/0007/1438/71438v1-max-250x250.png"],
             [[351,
               88],
              "assets/images/resized/0007/1438/71438v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "128 Spring Street",
    "address2": "Suite 620",
    "zip_code": "02421",
    "city": "Lexington",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        90],
       "assets/images/resized/0017/4292/174292v1-max-150x150.png"],
      [[250,
        151],
       "assets/images/resized/0017/4292/174292v1-max-250x250.png"],
      [[450,
        272],
       "assets/images/resized/0017/4292/174292v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}